Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (91-100 of 237) with videos related to

Pageof 24
Sort By:
Molecular Pharmaceutics|June 3, 2011
Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transportersSuneet Shukla, Amanda P Skoumbourdis, Martin J Walsh, et al.
Biochemistry|March 16, 2005
Activation of camptothecin derivatives by conjugation to triple helix-forming oligonucleotidesPaola B Arimondo, Gary S Laco, Craig J Thomas, et al.
Cell Death & Disease|December 2, 2016
Large-scale pharmacological profiling of 3D tumor models of cancer cellsLesley A Mathews Griner, Xiaohu Zhang, Rajarshi Guha, et al.
Cancers|December 18, 2020
Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian CancerAnne M Noonan, Amanda Cousins, David Anderson, et al.
Nature Medicine|November 26, 2013
CD28 and ITK signals regulate autoreactive T cell traffickingNitya Jain, Bing Miu, Jian-kang Jiang, et al.
Journal of Medicinal Chemistry|September 14, 2019
Targeting of Fumarate Hydratase from <i>Mycobacterium tuberculosis</i> Using Allosteric Inhibitors with a Dimeric-Binding ModeAndrew J Whitehouse, M Daben J Libardo, Monica Kasbekar, et al.
Frontiers in Immunology|January 11, 2020
JAK Inhibition Differentially Affects NK Cell and ILC1 HomeostasisLaura Vian, Mimi T Le, Nathalia Gazaniga, et al.
Journal of Medicinal Chemistry|June 23, 2006
Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patternsSusanna Moore, Holger Jaeschke, Gunnar Kleinau, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)Bryan T Mott, Cordelle Tanega, Min Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124Douglas S Auld, Scott Lovell, Natasha Thorne, et al.
Pageof 24

Showing results (91-100 of 237) with videos related to

Sort By:
Pageof 24
Molecular Pharmaceutics|June 3, 2011
Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transportersSuneet Shukla, Amanda P Skoumbourdis, Martin J Walsh, et al.
Biochemistry|March 16, 2005
Activation of camptothecin derivatives by conjugation to triple helix-forming oligonucleotidesPaola B Arimondo, Gary S Laco, Craig J Thomas, et al.
Cell Death & Disease|December 2, 2016
Large-scale pharmacological profiling of 3D tumor models of cancer cellsLesley A Mathews Griner, Xiaohu Zhang, Rajarshi Guha, et al.
Cancers|December 18, 2020
Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian CancerAnne M Noonan, Amanda Cousins, David Anderson, et al.
Nature Medicine|November 26, 2013
CD28 and ITK signals regulate autoreactive T cell traffickingNitya Jain, Bing Miu, Jian-kang Jiang, et al.
Journal of Medicinal Chemistry|September 14, 2019
Targeting of Fumarate Hydratase from <i>Mycobacterium tuberculosis</i> Using Allosteric Inhibitors with a Dimeric-Binding ModeAndrew J Whitehouse, M Daben J Libardo, Monica Kasbekar, et al.
Frontiers in Immunology|January 11, 2020
JAK Inhibition Differentially Affects NK Cell and ILC1 HomeostasisLaura Vian, Mimi T Le, Nathalia Gazaniga, et al.
Journal of Medicinal Chemistry|June 23, 2006
Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patternsSusanna Moore, Holger Jaeschke, Gunnar Kleinau, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)Bryan T Mott, Cordelle Tanega, Min Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124Douglas S Auld, Scott Lovell, Natasha Thorne, et al.
Pageof 24